Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb:40:743-750.
doi: 10.1016/j.ebiom.2019.01.021. Epub 2019 Jan 17.

Krϋppel-like factors (KLFs) in renal physiology and disease

Affiliations
Review

Krϋppel-like factors (KLFs) in renal physiology and disease

Madhavi J Rane et al. EBioMedicine. 2019 Feb.

Abstract

Dysregulated Krϋppel-like factor (KLF) gene expression appears in many disease-associated pathologies. In this review, we discuss physiological functions of KLFs in the kidney with a focus on potential pharmacological modulation/therapeutic applications of these KLF proteins. KLF2 is critical to maintaining endothelial barrier integrity and preventing gap formations and in prevention of glomerular endothelial cell and podocyte damage in diabetic mice. KLF4 is renoprotective in the setting of AKI and is a critical regulator of proteinuria in mice and humans. KLF6 expression in podocytes preserves mitochondrial function and prevents podocyte apoptosis, while KLF5 expression prevents podocyte apoptosis by blockade of ERK/p38 MAPK pathways. KLF15 is a critical regulator of podocyte differentiation and is protective against podocyte injury. Loss of KLF4 and KLF15 promotes renal fibrosis, while fibrotic kidneys have increased KLF5 and KLF6 expression. For therapeutic modulation of KLFs, continued screening of small molecules will promote drug discoveries targeting KLF proteins.

Keywords: Fibrosis; Interstitial inflammation; Kidney disease; Krϋppel-like factors (KLFs); Podocytes; Renal tubule cells.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic comparison of various domains of KLFs discussed in this review.

References

    1. Kaczynski J., Cook T., Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol. 2003;4(2):206. - PMC - PubMed
    1. Miller I.J., Bieker J.J. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol. 1993;13(5):2776–2786. - PMC - PubMed
    1. Pei J., Grishin N.V. A new family of predicted krüppel-like factor genes and pseudogenes in placental mammals. PLoS One. 2013;8(11) - PMC - PubMed
    1. Conkright M.D., Wani M.A., Lingrel J.B. Lung Kruppel-like factor contains an autoinhibitory domain that regulates its transcriptional activation by binding WWP1, an E3 ubiquitin ligase. J Biol Chem. 2001;276(31):29299–29306. - PubMed
    1. Geiman D.E., Ton-That H., Johnson J.M., Yang V.W. Transactivation and growth suppression by the gut-enriched Kruppel-like factor (Kruppel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction. Nucleic Acids Res. 2000;28(5):1106–1113. - PMC - PubMed

MeSH terms